Researcher – Professor Hing Leung
Institution - University of Glasgow
Grant award - £463,460
Reference – PG14-009-TR2

Hing leung

In a nutshell

This project addresses whether adding statins to hormone treatment will improve treatment response in hormone resistant disease, and whether any new tests can track how well the cancer is responding.

Why we funded it

This project could provide an avenue to use statins and hormone manipulation in patients with lethal prostate cancer where standard hormone treatment tends not to work well. If successful, the information from this study will inform a larger clinical trial with the end-goal to make this routine clinical practice for patients with hormone resistant prostate cancer. The researchers also plan to identify a new tracking device for monitoring the response to this treatment.

Download digital versions of this research summary